CN112552224A - Synthesis method of 4-hydroxyindole - Google Patents

Synthesis method of 4-hydroxyindole Download PDF

Info

Publication number
CN112552224A
CN112552224A CN202011628332.6A CN202011628332A CN112552224A CN 112552224 A CN112552224 A CN 112552224A CN 202011628332 A CN202011628332 A CN 202011628332A CN 112552224 A CN112552224 A CN 112552224A
Authority
CN
China
Prior art keywords
compound
reaction
hours
solvent
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011628332.6A
Other languages
Chinese (zh)
Inventor
庄明晨
陶康
谢坤山
亢兴龙
徐兴兵
郭鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astatech Chengdu Pharm Co ltd
Original Assignee
Astatech Chengdu Pharm Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astatech Chengdu Pharm Co ltd filed Critical Astatech Chengdu Pharm Co ltd
Priority to CN202011628332.6A priority Critical patent/CN112552224A/en
Publication of CN112552224A publication Critical patent/CN112552224A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)

Abstract

The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis method of 4-hydroxyindole. Aiming at the problems in the industrial production of 4-hydroxyindole in the prior art, the technical scheme of the invention is that the method comprises the following steps: (1) protecting hydroxyl in the compound 3 with a protecting group to obtain a compound 4; (2) reacting the compound 4 with N, N-dimethylformamide dimethyl acetal to obtain a compound 5; (3) reacting compound 5 with NH2NH2·H2Mixing O and MeOH, and reacting to obtain a compound 6; (4) removing the protecting group of the compound 6 to obtain the 4-hydroxyindole. The method for synthesizing the 4-hydroxyindole has the advantages of low cost of initial raw materials, mild reaction conditions in the synthesis process, convenient operation, simple post-treatment and high yield.

Description

Synthesis method of 4-hydroxyindole
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis method of 4-hydroxyindole.
Background
Oxindoles are starting materials for the synthesis of many natural compounds, and in many of the natural products and pharmaceutically active compounds found, the indole core often serves as a significant structural unit. Therefore, the development of new methods for the synthesis of indole core backbones with different substitution patterns is an important goal of current organic synthesis. It is well known that many of these indole derivatives are intermediates for the synthesis of physiologically active drugs.
4-hydroxyindole is an important organic chemical raw material and intermediate, can be used for synthesizing dye, spice and some medicines, and can also be used as auxin, feed additive and the like. 4-hydroxyindole is also an important intermediate for the synthesis of a large number of physiologically active compounds, such as Pindolo1 and 4-hydroxytryptamine Psilocin.
In recent years, many methods for synthesizing 4-hydroxyindole have been described in the literature, for example:
the synthesis method of the nitrogen heterocyclic ring styrene under the catalysis of palladium has the advantages of rigorous synthesis reaction conditions, use of expensive reagents, difficult post-treatment, long reaction time and total reaction yield of 29 percent. The one-step synthesis method for reducing 1, 5, 6, 7-tetrahydro-4H-indole 4-ketone by palladium-carbon has long reaction time and complex post-treatment. Torrii et al reported a convenient method for synthesizing 4-hydroxyindole, which uses 2, 4-dinitrotoluene and paraformaldehyde as starting materials to synthesize 2, 4-dinitrophenethyl alcohol by an electrochemical method, under the condition of 5-9MPa hydrogen, Raney Ni reduces 2, 4-dinitrophenethyl alcohol to obtain 2, 4-aminophenylethanol, 70% phosphoric acid is cyclized at 220 ℃ to generate 4-hydroxyindoline, 4-hydroxyindole is obtained by Pd/C reduction, and the total yield of the route is 54.72%. However, this method uses high temperature and high pressure, and is not suitable for industrial production. The 4-hydroxyindole is also synthesized by using m-nitrophenol as a raw material, but the m-nitrophenol is expensive and belongs to a dangerous article.
The synthesis method adopted in the industry at present has a long route, and the method comprises the steps of using resorcinol as a raw material, obtaining 1, 3-cyclohexanedione through catalytic hydrogenation and isomerization, using ethyl lactate as a raw material, obtaining brominated ethyl bromopyruvate, cyclizing the brominated ethyl bromopyruvate and the brominated ethyl bromopyruvate to obtain 4-oxo-tetrahydro-L-maleopimaric acid, adding the 4-oxo-tetrahydro-L-maleopimaric acid into a methanol solution saturated by ammonia, heating in a high-pressure kettle for reaction to generate 4-oxo-tetrahydro indole, and finally obtaining the 4-hydroxy-indole through dehydrogenation and isomerization. The method has the disadvantages of high requirement on equipment, complex operation and high cost.
In conclusion, the method for synthesizing 4-hydroxyindole in the prior art has the problems of high raw material cost, harsh reaction conditions, high equipment requirements, long reaction time, inconvenient post-treatment and the like, so that the method is not beneficial to industrial production.
Disclosure of Invention
Aiming at the problems in the industrial production of 4-hydroxyindole in the prior art, the invention provides a synthesis method of 4-hydroxyindole, which aims to: the cost of the synthetic starting material is reduced, the reaction condition in the synthetic process is mild, the operation is convenient, the post-treatment is simple, and the yield is high.
A synthetic method of 4-hydroxyindole is carried out by the following synthetic route:
Figure BDA0002875509340000021
wherein R is a protecting group;
which comprises the following steps:
(1) protecting hydroxyl in the compound 3 with a protecting group to obtain a compound 4;
(2) reacting the compound 4 with N, N-dimethylformamide dimethyl acetal to obtain a compound 5;
(3) mixing the compound 5 with a reducing agent and a catalyst and then reacting to obtain a compound 6;
(4) removing the protecting group of the compound 6 to obtain the 4-hydroxyindole.
Preferably, R is selected from alkyl or benzyl.
Preferably, the specific process of step (1) is as follows: mixing the compound 3 with alkali, dissolving in a solvent, slowly adding RBr under the protection of inert gas, heating for reaction after the dropwise addition is finished, and separating and purifying after the reaction is finished to obtain a compound 4;
preferably, the base is selected from K2CO3、Na2CO3、Cs2CO3Or NaH; and/or, the solvent is selected from at least one of DMF, THF, DCM or EtOAc; and/or controlling the temperature to be 25-30 ℃ in the process of slowly adding the RBr; and/or the temperature of the heating reaction is 30-80 ℃, preferably 60 ℃; and/or the heating reaction time is 10 to 14 hours, preferably 12 hours; and/or the dosage ratio of the compound 3 to the RBr is 1 eq: 1-1.4eq, preferably 1 eq: 1.2 eq.
Preferably, the specific processes of step (2) and step (3) are as follows:
(2) dissolving a compound 4 and N, N-dimethylformamide dimethyl acetal in a solvent, and heating for reaction to obtain a reaction solution containing a compound 5;
(3) after the temperature of the reaction solution is reduced to room temperature, adding a reducing agent and a catalyst for heating reaction, and separating and purifying after the reaction is finished to obtain a reactant 6;
preferably, the solvent is selected from at least one of DMF, THF, DCM or EtOA; and/or the temperature of the heating reaction in the step (2) is 100-120 ℃, preferably 100 ℃; and/or the heating reaction time in the step (2) is 12 to 24 hours, preferably 24 hours; and/or the temperature of the heating reaction in the step (3) is 70-100 ℃, preferably 100 ℃; and/or the heating reaction time of the step (3) is 10 to 14 hours, preferably 12 hours; and/or the compound 4 and the N, N-dimethylformamide dimethyl acetal are used in a ratio of 1 eq: 3 to 5eq, preferably 1 eq: 4 eq; and/or the compound 4, the reducing agent and the catalyst are used in a proportion of 1 eq: 4-6 eq: 0.05 to 0.15eq, preferably 1 eq: 5 eq: 0.1 eq.
Preferably, in the step (3), the reducing agent is NH2NH2·H2O, the catalyst is FeCl3At least one of Ni, NiB or Carbon; and/or the reducing agent is H2The catalyst is at least one of Pd/C or Pt/C.
Preferably, the specific process of step (4) is as follows: dissolving the compound 6 in a solvent, adding a catalyst, reacting in a hydrogen atmosphere, and separating and purifying after the reaction is finished to obtain 4-hydroxyindole;
preferably, the solvent is selected from at least one of MeOH, EtOH or THF; and/or the catalyst is at least one of Pd/C, Pt/C, PtO2 or Raney nickel.
Preferably, said compound 3 is synthesized by the following synthetic route:
Figure BDA0002875509340000031
reacting the compound 1 with methanol to obtain a compound 2;
(II) reacting Compound 2 with BBr3Reaction to give compound 3.
Preferably, the specific process of step (I) is as follows: dissolving the compound 1, a catalyst, alkali and methanol in a solvent, heating and reacting under the protection of inert gas, and separating and purifying after the reaction is finished to obtain a compound 2;
preferably, the solvent is selected from at least one of toluene, benzene or dioxane; and/or, the catalyst is selected from BrettPhos Pd G3; and/or, the alkali is selected from Cs2CO3(ii) a And/or the temperature of the heating reaction is 60-80 ℃, preferably 70 ℃; and/or the heating reaction time is 14 to 18 hours, preferably 16 hours; and/or the dosage ratio of the compound 1 to the methanol is 1 eq: 5 to 20eq, preferably 1 eq: 10 eq.
Preferably, the specific process of step (ii) is: dissolving Compound 2 in solvent, and slowly adding BBr at low temperature3Reacting at room temperature, and separating and purifying after the reaction is finished to obtain a compound 3;
preferably, the solvent is selected from at least one of DCM or THF; and/or, adding BBr3The temperature of (a) is-5 to 0 ℃; and/or the reaction time is 1 to 12 hours, preferably 12 hours; and/or, said compound 2 with BBr3The dosage proportion is 1 eq: 1-1.4eq, preferably 1 eq: 1.2 eq.
The invention also provides the 4-hydroxyindole prepared by the synthesis method.
The technical scheme provided by the invention for synthesizing the 4-hydroxyindole has the advantages of mild reaction conditions, convenience in operation, simplicity in post-treatment and high yield. Compared with the prior art, the 4-hydroxyindole product is directly obtained after the cyclization reaction is finished, and further dehydrogenation reaction is not needed, so that the method does not need high-temperature and high-pressure conditions, and special equipment such as a high-pressure reaction kettle and the like is not needed, and the production cost of the method is greatly reduced. In the preferred scheme, the synthesized starting material compound 1 is low in price and convenient to obtain, and the production cost is favorably reduced.
Obviously, many modifications, substitutions, and variations are possible in light of the above teachings of the invention, without departing from the basic technical spirit of the invention, as defined by the following claims.
The present invention will be described in further detail with reference to the following examples. This should not be understood as limiting the scope of the above-described subject matter of the present invention to the following examples. All the technologies realized based on the above contents of the present invention belong to the scope of the present invention.
Detailed Description
Example 1
The synthetic route of the embodiment is as follows:
Figure BDA0002875509340000041
this example of a process for preparing 4-hydroxyindole includes the following steps:
1. preparation of compound 2:
Figure BDA0002875509340000051
the method comprises the following specific operations:
(1) 1-chloro-2-methyl-3-nitrobenzene (100g,1eq), BrettPhos, was added at room temperature Pd G3(0.53g,0.001eq),Cs2CO3(379.78g,2eq) and methanol (186.74g,10eq) were added to 500mL of toluene, and the reaction mixture was stirred under N2The temperature is raised to 70 ℃ under protection and the reaction is carried out for 16 hours.
(2) Less than 5% of the control starting material remained in the TLC plate, and one main spot was generated.
(3) The reaction solution was cooled to room temperature and added to 1L of water. The aqueous phase was extracted with ethyl acetate (500 mL. times.3) and the organic phases were combined. Washing the organic phase with saturated saline (800ML × 1), drying with anhydrous sodium sulfate, decolorizing with 5g of activated carbon, filtering with 0.1kg of silica gel;
(4) the organic phase is condensed to be dry, petroleum ether (0.5L) is added for pulping, and 72g of product is obtained after drying, and the yield is 73.9%.
Results of nuclear magnetic resonance testing of compound 2:1HNMR(400MHz,CDCl3):2.35(3H,s),3.85(3H,s),7.05(1H,m),7.21(1H,m),7.37(1H,m).
2. preparation of Compound 3
Figure BDA0002875509340000052
The method comprises the following specific operations:
(1) dissolving the compound 2(72g,1eq) in 400ML DCM, cooling the reaction system to-5 ℃ and N2Slow BBr under protection3(130g,1.2eq) and the temperature was controlled at-5-0 ℃. After the dropwise addition, naturally heating to room temperature, and reacting for 12 hours;
(2) TLC monitoring completion of the reaction;
(3) cooling the reaction system to 0 ℃, slowly dropping 200ML of water to quench the reaction, and using saturated Na2CO3The pH of the system was adjusted to 8 and the aqueous phase was extracted with DCM (400ML × 2). Mixing the organic phases, adding anhydrous sodium sulfate, drying, decolorizing with 5g of activated carbon, and filtering with 0.1kg of silica gel;
(4) the organic phase is condensed to be dry, added with petroleum ether (0.1L) for pulping and dried to obtain 46g of product with the yield of 69.7 percent.
Results of nuclear magnetic resonance testing of compound 3:1HNMR(400MHz,CDCl3):2.38(3H,s),5.32(1H,s),7.02(1H,m),7.19(1H,m),7.47(1H,m).
3. preparation of Compound 4
Figure BDA0002875509340000061
The method comprises the following specific operations:
(1) mixing compound 3(46g,1eq) with K2CO3(106.5g,2eq) in 250ML DMF, N2The BnBr (61.7g,1.2eq) was slowed under protection and the temperature was controlled at 25-30 ℃. After the dropwise addition, heating to 60 ℃ for reaction for 12 hours;
(2) TLC monitoring completion of the reaction;
(3) the reaction was cooled to 25 ℃, 400ML of water was added, and the aqueous phase was extracted with ethyl acetate (400ML × 3). The organic phases were combined, washed with saturated brine (400ML × 3), dried over anhydrous sodium sulfate, decolorized with 3g of activated carbon, filtered over 0.1kg of silica gel;
(4) the organic phase is condensed to be dry, added with petroleum ether (0.1L) for pulping and dried to obtain 35.5g of product with the yield of 48.6 percent.
Results of nuclear magnetic resonance testing of compound 4:1HNMR(400MHz,CDCl3):2.46(3H,s),5.10(2H,s),7.08(1H,m),7.24(1H,m),7.30-7.50(6H,m).
4. preparation of Compound 6
Figure BDA0002875509340000062
The method comprises the following specific operations:
(1) dissolving compound 4(35.5g,1eq) and DMF-DMA (69.6g,4eq) in 100ML DMF, and heating to 120 ℃ for reaction for 24 hours;
(2) TLC monitoring completion of the reaction;
(3) reducing the temperature of the reaction system to 25 ℃, adding FeCl3(2.4g,0.1eq) and NH2NH2·H2O (36.5g,5eq), and the reaction system was heated to 100 ℃ for 12 hours.
(4) TLC monitoring completion of the reaction;
(5) 150ML of water was added to the reaction system, and the aqueous phase was extracted with ethyl acetate (200 ML. times.3). Mixing organic phases, washing with saturated saline (200ML × 3), drying with anhydrous sodium sulfate, decolorizing with 3g of activated carbon, and filtering with 0.1kg of silica gel;
(6) the organic phase is combined and concentrated to obtain a crude product, and the crude product is purified by column chromatography to obtain 15g of a product, wherein the yield is 46.0%.
Results of nuclear magnetic resonance testing of compound 6:1HNMR(400MHz,CDCl3):5.32(2H,s),6.68-6.70(1H,d),680(1H,s),7.02-7.10(2H,m),7.13-7.20(1H,t),7.37-7.55(3H,m),7.55-7.66(2H,m),8.20-8.45(1H,m)。
5. preparation of 4-hydroxyindoles
Figure BDA0002875509340000071
The method comprises the following specific operations:
(1)N2compound 6(15g,1eq) was dissolved in 100ML MeOH under protection, and Pd/C (0.15g,0.1eq), H, was added to the reaction system2Replacement 3 times, H2Reacting at room temperature for 12 hours under the protection of (15 psi);
(2) TLC monitoring completion of the reaction;
(3) Pd/C is filtered, mother liquor is concentrated to obtain a crude product, the crude product is pulped by petroleum ether ethyl acetate (PE: EA-10:1) to obtain 8g of product, and the yield is 89.4%.
Results of nuclear magnetic resonance testing of 4-hydroxyindole:1HNMR(DMSO-d6):6.35(1H,d),6.46(1H,d),6.81-6.87(2H,t),7.14(1H,s),9.25(1H,s),10.90(1H,m).
the examples show that 4-hydroxyindole can be prepared by the method provided by the invention, the starting material is compound 1, and the method is low in price, convenient to obtain and beneficial to reduction of production cost. In addition, the method has the advantages of mild reaction conditions (the highest temperature is 120 ℃), convenient operation, simple post-treatment and high yield.

Claims (10)

1. The synthesis method of the 4-hydroxyindole is characterized by comprising the following synthetic routes:
Figure FDA0002875509330000011
wherein R is a protecting group;
which comprises the following steps:
(1) protecting hydroxyl in the compound 3 with a protecting group to obtain a compound 4;
(2) reacting the compound 4 with N, N-dimethylformamide dimethyl acetal to obtain a compound 5;
(3) mixing the compound 5 with a reducing agent and a catalyst and then reacting to obtain a compound 6;
(4) removing the protecting group of the compound 6 to obtain the 4-hydroxyindole.
2. A method of synthesis according to claim 1, characterized in that: and R is selected from alkyl or benzyl.
3. A method of synthesis according to claim 1, characterized in that: the specific process of the step (1) is as follows: mixing the compound 3 with alkali, dissolving in a solvent, slowly adding RBr under the protection of inert gas, heating for reaction after the dropwise addition is finished, and separating and purifying after the reaction is finished to obtain a compound 4;
preferably, the base is selected from K2CO3、Na2CO3、Cs2CO3Or NaH; and/or, the solvent is selected from at least one of DMF, THF, DCM or EtOAc; and/or controlling the temperature to be 25-30 ℃ in the process of slowly adding the RBr; and/or the temperature of the heating reaction is 30-80 ℃, preferably 60 ℃; and/or the heating reaction time is 10 to 14 hours, preferably 12 hours; and/or the dosage ratio of the compound 3 to the RBr is 1 eq: 1-1.4eq, preferably 1 eq: 1.2 eq.
4. A method of synthesis according to claim 1, characterized in that: the specific processes of the step (2) and the step (3) are as follows:
(2) dissolving a compound 4 and N, N-dimethylformamide dimethyl acetal in a solvent, and heating for reaction to obtain a reaction solution containing a compound 5;
(3) after the temperature of the reaction solution is reduced to room temperature, adding a reducing agent and a catalyst for heating reaction, and separating and purifying after the reaction is finished to obtain a reactant 6;
preferably, the solvent is selected from at least one of DMF, THF, DCM or EtOA; and/or the temperature of the heating reaction in the step (2) is 100-120 ℃, preferably 100 ℃; and/or the heating reaction time in the step (2) is 12 to 24 hours, preferably 24 hours; and/or the temperature of the heating reaction in the step (3) is 70-100 ℃, preferably 100 ℃; and/or the heating reaction time of the step (3) is 10 to 14 hours, preferably 12 hours; and/or the compound 4 and the N, N-dimethylformamide dimethyl acetal are used in a ratio of 1 eq: 3 to 5eq, preferably 1 eq: 4 eq; and/or the compound 4, the reducing agent and the catalyst are used in a proportion of 1 eq: 4-6 eq: 0.05 to 0.15eq, preferably 1 eq: 5 eq: 0.1 eq.
5. A method of synthesis according to claim 1, characterized in that: in the step (3), the reducing agent is NH2NH2·H2O, the catalyst is FeCl3At least one of Ni, NiB or Carbon; and/or the reducing agent is H2The catalyst is at least one of Pd/C or Pt/C.
6. A method of synthesis according to claim 1, characterized in that: the specific process of the step (4) is as follows: dissolving the compound 6 in a solvent, adding a catalyst, reacting in a hydrogen atmosphere, and separating and purifying after the reaction is finished to obtain 4-hydroxyindole;
preferably, the solvent is selected from at least one of MeOH, EtOH or THF; and/or the catalyst is at least one of Pd/C, Pt/C, PtO2 or Raney nickel.
7. A method of synthesis according to claim 1, characterized in that: the compound 3 was synthesized by the following synthetic route:
Figure FDA0002875509330000021
reacting the compound 1 with methanol to obtain a compound 2;
(II) reacting Compound 2 with BBr3Reaction to give compound 3.
8. The synthesis method according to claim 7, wherein the specific process of step (I) is as follows: dissolving the compound 1, a catalyst, alkali and methanol in a solvent, heating and reacting under the protection of inert gas, and separating and purifying after the reaction is finished to obtain a compound 2;
preferably, the solvent is selected from at least one of toluene, benzene or dioxane; and/or, the catalyst is selected from BrettPhos Pd G3; and/or, the alkali is selected from Cs2CO3(ii) a And/or the temperature of the heating reaction is 60-80 ℃, preferably 70 ℃; and/or the heating reaction time is 14 to 18 hours, preferably 16 hours; and/or the dosage ratio of the compound 1 to the methanol is 1 eq: 5 to 20eq, preferably 1 eq: 10 eq.
9. The synthesis method according to claim 7, wherein the specific process of step (II) is as follows: dissolving Compound 2 in solvent, and slowly adding BBr at low temperature3Reacting at room temperature, and separating and purifying after the reaction is finished to obtain a compound 3;
preferably, the solvent is selected from at least one of DCM or THF; and/or, adding BBr3The temperature of (a) is-5 to 0 ℃; and/or the reaction time is 1 to 12 hours, preferably 12 hours; and/or, said compound 2 with BBr3The dosage proportion is 1 eq: 1-1.4eq, preferably 1 eq: 1.2 eq.
10. 4-hydroxyindole prepared by the synthesis method of any one of claims 1 to 9.
CN202011628332.6A 2020-12-30 2020-12-30 Synthesis method of 4-hydroxyindole Pending CN112552224A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011628332.6A CN112552224A (en) 2020-12-30 2020-12-30 Synthesis method of 4-hydroxyindole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011628332.6A CN112552224A (en) 2020-12-30 2020-12-30 Synthesis method of 4-hydroxyindole

Publications (1)

Publication Number Publication Date
CN112552224A true CN112552224A (en) 2021-03-26

Family

ID=75035032

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011628332.6A Pending CN112552224A (en) 2020-12-30 2020-12-30 Synthesis method of 4-hydroxyindole

Country Status (1)

Country Link
CN (1) CN112552224A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115260037A (en) * 2022-08-09 2022-11-01 西安拓超生物科技有限公司 Preparation method of 2-methyl-3-nitrobenzyl ether
CN115536571A (en) * 2022-11-09 2022-12-30 上海裕兰生物科技有限公司 Preparation method of indole derivative

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100094000A1 (en) * 2008-09-03 2010-04-15 Takeda Pharmaceutical Company Limited Pyrazole compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100094000A1 (en) * 2008-09-03 2010-04-15 Takeda Pharmaceutical Company Limited Pyrazole compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
I. V. TAYDAKOV,等: "Convenient modification of the Leimgruber-Batcho indole synthesis: reduction of 2-nitro-β-pyrrolidinostyrenes by the FeCl3-activated carbon-N2H4.H2O system", 《CHEMISTRY OF HETEROCYCLIC COMPOUNDS》 *
LAWRENCE I. KRUSE: "Synthesis of 4-substituted indoles from o-nitrotoluenes", 《HETEROCYCLES》 *
T. M. RANGARAJAN,等: "Mild and efficient palladium/BrettPhos-catalyzed methoxylation and deuteriomethoxylation of activated aryl bromides", 《TETRAHEDRON LETTERS》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115260037A (en) * 2022-08-09 2022-11-01 西安拓超生物科技有限公司 Preparation method of 2-methyl-3-nitrobenzyl ether
CN115536571A (en) * 2022-11-09 2022-12-30 上海裕兰生物科技有限公司 Preparation method of indole derivative
CN115536571B (en) * 2022-11-09 2024-03-29 上海裕兰生物科技有限公司 Preparation method of indole derivative

Similar Documents

Publication Publication Date Title
CN112552224A (en) Synthesis method of 4-hydroxyindole
CN112679420B (en) Preparation method of 2,5-dibromopyridine
JP7038263B2 (en) Method for Producing Morpholine Quinazoline Compound and its Intermediate
CN113248432A (en) Novel method for preparing intermediate of roxasistat in high yield
CN114920699B (en) Method for preparing 6-chloro-2-methyl-2H-indazol-5-amine
CN112300072A (en) High-yield synthesis method of 5-iodoisoquinoline compounds
CN116120236A (en) Preparation method of 6-chloro-2-methyl-2H-indazole-5-amine
CN111100042B (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
CN111499528B (en) Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate by using terbutaline sulfate intermediate
CN109503473B (en) Synthesis method of 2-methoxy-3-amino-5-pyridine boronic acid pinacol ester and intermediate thereof
CN115611860B (en) Method for synthesizing nilaparib
CN107501159B (en) Synthesis method of vilazodone intermediate 3- (4-chlorobutyl) -5-cyanoindole
EP0266033B1 (en) Process for the preparation of indolinone-2 derivatives
CN116874411B (en) Synthesis method of 1-bromocarbazole
CN113387804B (en) Synthesis method of alpha-asarone acetate and alpha-octanol
CN113264919B (en) Preparation method of 1- (2-methoxypyridine-4-yl) -1H-pyrazole-4-amine
CN114163354B (en) Preparation method of N-fluorenylmethoxycarbonyl-N-trityl-L-asparagine
CN112694432B (en) Preparation method of arbidol key intermediate
CN111004141B (en) New method for synthesizing nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide
CN108484481B (en) Synthesis method of dihydro-1H-indene spiro compound
CN110002930B (en) Method for hydrogenation reduction of alkenyl aromatic halogenated derivatives
CN111484417B (en) Preparation method of halofantrine hydrochloride
CN108558751B (en) Synthesis process of 3-nitroquinoline derivative
CN108558750B (en) Process for synthesizing 3-nitroquinoline derivative by solvent-free method
JPS59130832A (en) 4-halogeno-2-chloro-3-phenylcrotonaldehyde

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210326